Health and Wellness

Tiered Copays: Why Your Generic Prescription Might Cost More Than Expected

  • Home
  • Tiered Copays: Why Your Generic Prescription Might Cost More Than Expected
Tiered Copays: Why Your Generic Prescription Might Cost More Than Expected
20 December 2025 Casper MacIntyre

You pick up your prescription for levothyroxine, expecting to pay $5 like last month. Instead, the pharmacist says it’s $45. You check the bottle. It’s the same generic drug. Same dose. Same manufacturer. So why the huge jump?

Not All Generics Are Created Equal-By Your Insurer

The truth is, not all generic drugs are treated the same by your health plan. Even though they’re chemically identical to the brand-name version and to each other, insurers place them in different tiers based on one thing: money. Specifically, how much rebate the pharmacy benefit manager (PBM) got from the drugmaker.

Most health plans today use a tiered system with four or five levels. Tier 1 is for preferred generics-usually the cheapest, often $0 to $15. Tier 2 might be preferred brand-name drugs. Tier 3? That’s where things get confusing. This is often where non-preferred generics land-even if they’re exactly the same as the Tier 1 version.

Here’s the kicker: a generic drug can move from Tier 1 to Tier 3 overnight. No clinical reason. No safety issue. Just because the PBM’s contract with that manufacturer expired, and they didn’t renew it with a high enough rebate. That’s it.

How Tiered Copays Work (And Why They’re Not About Quality)

Think of tiers like a pricing ladder. The insurer wants you to pick the cheapest option. But they don’t pick it because it’s better. They pick it because they got paid to push it.

PBMs like Express Scripts, CVS Caremark, and OptumRx negotiate deals with drugmakers. The bigger the rebate, the lower the tier. A manufacturer might pay $10 per pill back to the PBM. If they pay $12, their generic lands in Tier 1. If they pay $8, it goes to Tier 2. The patient pays more, even though the drug is the same.

A 2023 analysis by BOC Pharmacy Group found that 12-18% of generic drugs are classified as specialty medications-meaning they’re stuck in Tier 4 or 5-even though they’re not complex to use. Why? Because they cost more than $600 a month to make, so the PBM puts them in a higher tier to offset the cost. That’s not about clinical need. It’s about accounting.

Why Your Levothyroxine Just Went from $5 to $45

Levothyroxine is one of the most common prescriptions in the U.S. and Australia. It’s a generic drug. Millions take it. But in 2024, UnitedHealthcare moved dozens of levothyroxine generics from Tier 1 to Tier 2 or 3 because their rebate deals changed. Patients saw their monthly cost jump from $5 to $40.

Same pill. Same effect. Same doctor’s note. But now you’re paying eight times more.

This isn’t rare. A 2023 Patient Advocate Foundation survey found that 41% of insured adults had a generic drug suddenly cost more-with no warning. And 68% couldn’t get a clear answer from their insurer.

On Reddit, users post weekly: "Why is my generic suddenly Tier 3?" One user wrote: "My doctor says all generics are the same. My pharmacist says the same. But my insurance says no-this one costs $45. Why?" No one ever gives a real answer.

Giant corporate figures tower over a ladder of pill bottles labeled with different prices, golden rebates flowing into their vaults.

Specialty Generics Are the New Wild West

Some generics aren’t just pills. They’re biologics-complex drugs made from living cells. When these lose patent protection, generic versions (called biosimilars) enter the market. But because they’re expensive to produce, insurers treat them like specialty drugs.

Take adalimumab, a generic version of Humira used for rheumatoid arthritis. Even though it’s a generic, it costs $5,000-$10,000 a month. Insurers put it in Tier 4 or 5. That means you pay 25-40% of that cost out of pocket. Even if you have good insurance, that’s $1,250-$4,000 a month.

And here’s the trap: you can’t just switch. These drugs are often the only thing keeping you from severe pain or flare-ups. But your insurer might try to swap you to a different biosimilar-just because it’s on a lower tier. That’s called a therapeutic interchange. And it doesn’t always work.

What You Can Do When Your Generic Gets Priced Up

You’re not powerless. Here’s what works:

  • Check your formulary every October. That’s when Medicare and most employer plans update their tiers. Use your insurer’s online tool-Humana’s Drug Cost Lookup or SmithRx’s tier comparison tool.
  • Ask your pharmacist if there’s a preferred generic. They often know which version your plan favors. Sometimes, they can switch you without a new prescription.
  • Request a tier exception. If your drug moved up and you’re stable on it, ask your doctor to file a form. The success rate is 63%, according to the Medicare Rights Center.
  • Use manufacturer coupons. Many drugmakers offer savings cards that cut costs by 50-80%. These work even on Tier 4 drugs.
  • Compare prices. Use GoodRx. Sometimes, paying cash at Walmart or Costco is cheaper than your copay.
A patient at night examines their insurance formulary as ghostly pills with different prices float around them, lit by laptop glow.

Why This System Exists (And Why It Won’t Disappear)

Tiered copays were created in the 1990s to slow rising drug prices. And they worked-sort of. Studies show they reduced spending on non-preferred brands by 15%. But they also created confusion, delays, and financial stress for patients.

The system survives because it’s profitable for PBMs, not patients. PBMs make money from rebates, not from helping you pay less. The more tiers they create, the more control they have over which drugs you get.

In 2024, Express Scripts moved 87 generic drugs to higher tiers-just because rebates dropped. No clinical reason. Just business.

The Inflation Reduction Act (2025) caps out-of-pocket drug costs at $2,000 a year for Medicare patients. That’s good. But it doesn’t touch tiering. Your copay might still be $45 for a $5 drug. You just won’t pay more than $2,000 total for the year.

What’s Next? Fewer Tiers, More Confusion

Industry analysts predict tier systems will simplify-from five tiers to four by 2026. But that doesn’t mean fairness. It means PBMs will group more drugs into fewer buckets, making it harder to predict costs.

Biosimilars will be the next battleground. Multiple generic versions of the same biologic will be slotted into different tiers. You might have three versions of adalimumab. One costs $100. One costs $500. One costs $1,200. All are clinically the same. But your plan picks the middle one. And you’re stuck with it.

The system isn’t broken. It’s working exactly as designed. For the insurers. Not for you.

Bottom Line: Know Your Plan. Ask Questions. Fight Back

Generic drugs are supposed to save you money. But under tiered systems, they can cost more than the brand name. And no one tells you why.

Your best defense? Stay informed. Check your formulary every year. Ask your pharmacist: "Is this the preferred version?" If your copay jumps, ask your doctor to file an exception. Don’t accept "that’s just how it is." It’s not. It’s a negotiation. And you’re the one paying for it.

You’re not overpaying because you’re doing something wrong. You’re paying more because someone else made a deal behind the scenes. And you deserve to know about it.

Why is my generic drug more expensive than the brand-name version?

It’s not about the drug-it’s about your plan’s contract with the manufacturer. Insurers assign tiers based on rebates, not clinical value. Sometimes, a generic gets placed in a higher tier because the drugmaker didn’t pay a big enough rebate to the pharmacy benefit manager (PBM). Even if the generic is chemically identical to the brand, it can cost more under your plan’s rules.

Can my insurer change my drug’s tier during the year?

Yes. While most formularies update in October, insurers can change tiers mid-year, especially for drugs where rebate deals expire. About 17% of commercial plans made changes between January and June 2023. You should get a notice, but many people miss it. Always check your plan’s formulary online if your copay suddenly increases.

What’s the difference between preferred and non-preferred generics?

There’s no clinical difference. Both generics contain the same active ingredient and work the same way. The terms "preferred" and "non-preferred" are purely financial. Preferred generics are the ones your insurer’s PBM negotiated the best rebate on. Non-preferred generics are the ones that didn’t offer enough money back to the PBM-even though they’re identical.

How do I find out which tier my drug is on?

Log into your insurer’s website and look for the "formulary" or "drug list" section. Most plans update this annually in October. You can also call your pharmacy or use tools like GoodRx or SmithRx to compare your plan’s tier pricing against other options. If you’re on Medicare, check the Medicare Plan Finder tool.

Can I appeal if my drug moves to a higher tier?

Yes. Ask your doctor to file a tier exception request. They’ll explain why you need this specific drug-for example, if you’ve been stable on it or if other versions caused side effects. Success rates are around 63%. If approved, your plan will cover it at the lower tier cost. Don’t assume it’s too late-appeals can be filed within 72 hours for urgent cases.

Are there programs to help pay for high-cost generics?

Yes. Many drug manufacturers offer patient assistance programs that can reduce your cost by 50-80%. These often work even for Tier 4 or 5 drugs. You can also use pharmacy discount cards like GoodRx or SingleCare. For specialty generics (like biosimilars), nonprofit organizations and state programs may offer additional help. Check with your pharmacist-they often know about these options.

Casper MacIntyre
Casper MacIntyre

Hello, my name is Casper MacIntyre and I am an expert in the field of pharmaceuticals. I have dedicated my life to understanding the intricacies of medications and their impact on various diseases. Through extensive research and experience, I have gained a wealth of knowledge that I enjoy sharing with others. I am passionate about writing and educating the public on medication, diseases, and their treatments. My goal is to make a positive impact on the lives of others through my work in this ever-evolving industry.

More Articles

Crohn's Disease and Gluten Intolerance: Key Signs and What to Watch For
Casper MacIntyre

Crohn's Disease and Gluten Intolerance: Key Signs and What to Watch For

Explore the link between Crohn's disease and gluten intolerance, learn warning signs, testing methods, and dietary steps to manage symptoms effectively.

Gout and the Immune System: Essential Guide to Managing Inflammation
Casper MacIntyre

Gout and the Immune System: Essential Guide to Managing Inflammation

Learn how urate crystals trigger the immune response in gout, the key inflammatory players, diet tips, and the best medications to prevent and treat flares.

Generic Drug Prices Over Time: Year-by-Year Changes and What Really Happens
Casper MacIntyre

Generic Drug Prices Over Time: Year-by-Year Changes and What Really Happens

Generic drug prices don't just drop over time - they spike unpredictably. See how competition, manufacturer exits, and supply chain issues cause year-by-year price swings that impact millions of Americans.